Patents by Inventor Stephen Edward Rapecki

Stephen Edward Rapecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140080134
    Abstract: The present invention provides the use of lipocalin 2 (LCN2) as a biomarker for IL-17 mediated diseases and for monitoring the response of a patient to anti-IL-17 therapy.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: UCB PHARMA S.A.
    Inventors: ADAM SAMUEL PLATT, STEPHEN EDWARD RAPECKI, MARA FORTUNATO, DAVID ROBERT RAINEY, JON LEIGH RUNDLE, PAUL ALFRED SMITH, GILLIAN SAIRFULL WATT
  • Publication number: 20140044732
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: September 24, 2013
    Publication date: February 13, 2014
    Applicant: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki
  • Patent number: 8617847
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: December 31, 2013
    Assignee: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki
  • Publication number: 20130245229
    Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
    Type: Application
    Filed: December 9, 2012
    Publication date: September 19, 2013
    Applicant: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki, Simon Peter Tickle
  • Patent number: 8435761
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods of producing the antibody molecules.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: May 7, 2013
    Assignee: UCB Pharma SA
    Inventors: Stephen Edward Rapecki, Andrew George Popplewell, Ralph Adams
  • Patent number: 8329431
    Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: December 11, 2012
    Assignee: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki, Simon Peter Tickle
  • Patent number: 8303953
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: November 6, 2012
    Assignee: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki
  • Patent number: 8231875
    Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
    Type: Grant
    Filed: November 16, 2005
    Date of Patent: July 31, 2012
    Assignee: UCB Pharma S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki, Simon Peter Tickle
  • Publication number: 20120129219
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods of producing the antibody molecules.
    Type: Application
    Filed: September 23, 2011
    Publication date: May 24, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Stephen Edward Rapecki, Andrew George Popplewell, Ralph Adams
  • Publication number: 20120034656
    Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
    Type: Application
    Filed: August 26, 2011
    Publication date: February 9, 2012
    Applicant: UCB PHARMA S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki, Simon Peter Tickle
  • Patent number: 8057794
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: November 15, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Stephen Edward Rapecki, Andrew George Popplewell, Ralph Adams
  • Patent number: 7931900
    Abstract: The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: April 26, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Mark Ian Christie, Richard James Mead, Martyn Kim Robinson, Stephen Edward Rapecki
  • Publication number: 20100266609
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: October 18, 2007
    Publication date: October 21, 2010
    Applicant: UCB PHARMA S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki
  • Publication number: 20100086538
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: June 25, 2007
    Publication date: April 8, 2010
    Applicant: UCB PHARMA S.A.
    Inventors: Stephen Edward Rapecki, Andrew George Popplewell, Ralph Adams
  • Publication number: 20090191200
    Abstract: The present invention provides a method for the treatment and/or prophylaxis of multiple sclerosis (MS) comprising administering a therapeutically effective amount of an inhibitor of IL-17 activity.
    Type: Application
    Filed: November 24, 2008
    Publication date: July 30, 2009
    Applicant: CELLTECH R&D LIMITED
    Inventors: Mark Ian Christie, Richard James Mead, Martyn Kim Robinson, Stephen Edward Rapecki
  • Publication number: 20090117126
    Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
    Type: Application
    Filed: November 16, 2005
    Publication date: May 7, 2009
    Applicant: UCB PHARMA S.A.
    Inventors: Ralph Adams, Andrew George Popplewell, Stephen Edward Rapecki, Simon Peter Tickle